Home / REKA.TA : TLV

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does REKA.TA make money? Does REKA.TA have pricing power? What's the Earnings Whisper? Will REKA.TA profit more as the business scales? What is REKA.TA's management track record? Is REKA.TA's current price justified?

Rekah Pharmaceutical Industry Ltd.

ILA 1020.00 -$73.00 (-6.68%)

TLV · 30 Oct 2026 11:44 UTC

Previous Close

ILA 1020.00

Day Range

ILA 1020.00ILA 1048.00

Year Range

ILA 1006.00ILA 1348.00

Market Cap

116.43M

AVG Volume

3.57K

Trailing/Forward PE

-7.34/-

PEG ratio

0.28

Dividend Yield

Next Earnings Date

Primary Exchange

Tel Aviv Stock Exchange

Revenue (ILS) · Q

REKA.TA Revenue (ILS) by quarter
Period	Revenue (ILS)
26 Q2	72.75M
26 Q1	79.31M
25 Q4	76.91M
25 Q3	75.07M
25 Q2	72.86M
25 Q1	76.15M
24 Q4	76.16M
24 Q3	87.19M
24 Q2	68.69M
24 Q1	89.67M

Net Income (ILS) · Q

REKA.TA Net Income (ILS) by quarter
Period	Net Income (ILS)
26 Q2	-1.32M
26 Q1	-2.88M
25 Q4	-6.29M
25 Q3	-5.33M
25 Q2	-4.05M
25 Q1	-2.41M
24 Q4	-2.32M
24 Q3	-4.67M
24 Q2	12M
24 Q1	1.2M

Operating Income (ILS) · Q

REKA.TA Operating Income (ILS) by quarter
Period	Operating Income (ILS)
26 Q2	-403K
26 Q1	-917K
25 Q4	-2.24M
25 Q3	-2.51M
25 Q2	-1.73M
25 Q1	23K
24 Q4	184K
24 Q3	-4.2M
24 Q2	17.62M
24 Q1	2.76M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (ILS) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Rekah Pharmaceutical Industry Ltd.

Earnings: REKA.TA

Video analysis: REKA.TA

News: REKA.TA

Similar companies